Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 1, 1997, Pages 3-10

  Bianchini, Pietro ^a,b   Liverani, Lino ^a   Mascellani, Giuseppe ^a   Parma, Bruna ^a  

^a Opocrin SpA   (Italy)

^b NONE   (Italy)

Author keywords

animal sources; biosynthesis; Heparin; HPLC analysis; organ sources

Indexed keywords

DISACCHARIDE; GLUCOSAMINE; GLUCOSAMINE SULFATE; HEPARIN DERIVATIVE;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANIMAL TISSUE; ANTICOAGULATION; CHICKEN; CONFERENCE PAPER; COW; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTESTINE; LUNG; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SHEEP; SPECIES DIFFERENCE; SULFATION; SWINE;

EID: 0030920641     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996063     Document Type: Conference Paper

References (18)

1. Lindahl U, D Feingold, L Roden: Biosynthesis of heparin. Trends Biochem Sci 11:221-225, 1986.
2. Mascellani G, L Liverani, P Bianchini: Analysis of heparin origin by HPLC quantitation of disaccharide components. II Farmaco 51:247-254, 1996.
3. European Pharmacopoeia, 2nd ed., 17th booklet, pp 333-333/4, 1993.
4. Mascellani G, L Liverani, B Parma, GL Bergonzini, P Bianchini: Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II. Thromb Res 84:21-32, 1996.
5. Casu B, M Guerrini, A Naggi, G Torri, L De Ambrosi, G Boveri, S Gonella, A Cedro, L Ferro, E Lanzarotti, M Paterno, M Attolini, MG Valle: Characterization of sulfation pattern of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy. Arzneim-Forsch/Drug Res 46:472-477, 1996.
6. Teien AN, M Lie: Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III. Thromb Res 10:339-410, 1977.
7. Thomson JM, L Poller: Blood Coagulation and Haemostasis. Churchill Livingstone, Edinburgh, 1985, p 301.
8. Rey NR, AS Perlin: Base-catalyzed conversions of the α-L-iduronic acid 2-sulphate unit of heparin into a unit of α-L-galacturonic acid, and related reactions. Carbohydr Res 200:437-447, 1990.
9. Jaseja M, RN Rej, F Sauriol, S Perlin: Novel regio and stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopy evidence. Can J Chem 67:1449-1456, 1989.
10. Lindahl U, L Thunberg, G Backstrom, J Riesenfeld, K Nordling, I Bjork: Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem 259:12368-12376, 1984.
11. Yamada S, K Sakamoto, H Tsuda, K Yoshida, K Sugahara, KH Khoo, K Morris, HR Dell: Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinase using them as substrates. Glycobiology 4:69-78, 1994.
12. Casu B: Methods for structural analysis. In: Lane DA, U Lindahl (Eds): Heparin, Chemical and Biological Properties. Clinical Application. Arnold, London, 1989, pp 25-49.
13. 1H nuclear magnetic resonance spectroscopy. Anal Biochem 223:135-141, 1994.
14. Metcalfe DD, RA Lewis, JE Silbert, RD Rosemberg, SI Wassermann, KF Austen: Isolation and characterization of heparin from human lung. J Clin Invest 64:1537-1543, 1979.
15. Linhardt RJ, SA Ampofo, J Fareed, D Hoppensteadt, JB Mulliken, J Folkman: Isolation and characterization of human heparin. Biochemistry 31:12441-12445, 1992.
16. Bianchini P, B Osima, MS Cetino, N Tellini, A Morani: Sostanze biologicamente attive in estratti di placenta. II Farmaco Ed Pr 32:139-151, 1977.
17. Lindahl U: Biosynthesis of heparin and related polysaccharides. In: Lane DA, U Lindahl (Eds): Heparin, Chemical and Biological Properties. Clinical Application. Arnold, London, 1989, pp 159-190.
18. Nader HB, CP Dietrich: Natural occurrence and possible biological role of heparin. In: Lane DA, U Lindahl (Eds): Heparin, Chemical and Biological Properties. Clinical Application. Arnold, London, 1989, pp 81-95.